Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
PURITAN MEDICAL
FOCUS DIAGNOSTICS, INC.

Molecular Diagnostic Tool Detects Toxoplasmic Encephalitis

By Labmedica International staff writers
Posted on 03 Apr 2012
Image: Toxoplasma gondii tachyzoites (Photo courtesy of Ke Hu and John Murray).
Image: Toxoplasma gondii tachyzoites (Photo courtesy of Ke Hu and John Murray).
A promising diagnostic tool has been developed to identify patients who are both immunocompromised and have the most common focal brain lesions.

The diagnostic accuracy, technical benefit, and clinical application of the duplex reverse transcription-polymerase chain reaction (duplex RT-PCR) assay have been assessed for the diagnosis toxoplasmic encephalitis (TE).

At the Mahidol University (Bangkok, Thailand) individuals with advanced human immunodeficiency virus (HIV) infection and central nervous system opportunistic infections were enrolled in a prospective study, performed from July 2007 to January 2009. Blood and cerebrospinal fluid samples were assayed by duplex RT-PCR to detect the genes of motile tachyzoite or the intracellular bradyzoite of Toxoplasma gondii.

The assay comprised three main steps: nucleic acid extraction, reverse transcription, and duplex polymerase chain reaction. Two sets of primers were used in this study, one specific to the tachyzoite surface antigen (SAG1) gene, and the other specific for the bradyzoite antigen (BAG1) gene. Originally, there were 70 HIV-infected patients eligible for the study, but only 61 could be analyzed. Altogether, there were eight confirmed TE cases, of which two were first episode and six were relapsed. Fifty-three were non-TE cases with other central nervous system opportunistic infections.

The duplex RT-PCR assay was performed on the MasterCycler-Gradient apparatus (Eppendorf; Hamburg, Germany) and showed high diagnostic accuracy, with 100% specificity and positive predictive value, as well as 87.5% sensitivity. Its efficacy reached 98.3%. This diagnostic method was rapid, needed only moderately skilled technicians, and was four times cheaper than previous standard procedures. It worked very well for blood samples, even after drug treatment had been started.

The authors concluded that the RT-PCR assay is also useful for the diagnosis of extracerebral toxoplasmosis in acquired immunodeficiency syndrome (AIDS) patients, in whom the clinical and radiological features are more difficult to interpret. Although serial specimens from AIDS patients are necessary for further evaluation of this technique, particularly from those who have TE with and without specific treatment, it can still be recommended for use as an alternative presumptive diagnostic procedure, especially in resource-poor settings. The study was published in the April 2012 issue of the International Journal of Infectious Diseases.

Related Links:
Mahidol University
Eppendorf


DIASYS DIAGNOSTIC SYSTEMS
KARL HECHT GMBH & CO KG
Dubai Bio Expo-2015

Channels

Genetic Tests

view channel
Image: The final result of a DNA sequencing process, with each color representing one of the four base chemicals, adenine, guanine, cytosine and thymine, that comprise DNA (Photo courtesy of Gerald Barber).

Gene Sequencing Reference Standard Increases Accuracy for Medical Laboratories

To reduce the variability in genetic test results that has been observed across different clinical laboratories and pathology groups, a new standard DNA reference has been introduced, which will improve... Read more

Hematology

view channel
Image: Immunochemistry of bone marrow biopsy from an acute myeloid leukemia patient showing sheets of CD34 positive cells; corresponding bone marrow aspirate showed only 20% blasts (Photo courtesy of All India Institute of Medical Sciences).

Immunohistochemistry Assesses Early Response in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a heterogeneous disease with respect to prognosis and early response assessment has an established role as predictor of remission rate, and overall and disease-free survival.... Read more

Industry News

view channel

Partners to Develop and Commercialize Noninvasive Tests for Bladder Cancer

An agreement between a major European university medical center and a multinational biotechnology company was designed to promote commercialization and further development of a liquid biopsy test for the diagnosis of bladder cancer. The liquid biopsy test is based on bladder cancer DNA methylation biomarkers developed... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.